Clinton Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-178,470
Closed -$2.84M 362
2018
Q1
$2.84M Buy
178,470
+78,470
+78% +$1.46M 0.3% 108
2017
Q4
$2.08M Buy
+100,000
New +$1.59M 0.18% 174
2017
Q2
Sell
-145,422
Closed -$1.6M 586
2017
Q1
$1.6M Buy
+145,422
New +$2M 0.09% 297
2016
Q4
Sell
-72,568
Closed -$1.78M 811
2016
Q3
$1.78M Sell
72,568
-104,359
-59% -$2.7M 0.08% 307
2016
Q2
$3.56M Buy
+176,927
New +$5.01M 0.16% 183
2016
Q1
Sell
-53,780
Closed -$5.47M 862
2015
Q4
$5.47M Buy
53,780
+36,957
+220% +$4.15M 0.44% 38
2015
Q3
$3M Buy
16,823
+5,813
+53% +$1.36M 0.28% 105
2015
Q2
$2.45M Buy
11,010
+7,407
+206% +$1.64M 0.34% 77
2015
Q1
$716K Buy
+3,603
New +$639K 0.19% 157

Other funds holding BHC

Clinton Group's BHC Position: Q2 2018 in Review

Clinton Group sold out of Bausch Health (BHC) in Q2 2018, closing a stake of 178,470 shares — an estimated $2.84M sold.

Clinton Group first reported a position in BHC in Q1 2015 and held it in 9 quarters. The position peaked at $5.47M in Q4 2015. 311 funds tracked by Wall St. Rank hold BHC as of Q2 2018.

  • Clinton Group reported no remaining Bausch Health position as of Q2 2018 after selling out during the quarter.
  • Clinton Group sold 178,470 Bausch Health shares in Q2 2018, an estimated $2.84M.
  • Clinton Group first reported a position in Bausch Health in Q1 2015 and held it in 9 quarters.
  • Clinton Group's Bausch Health position peaked at $5.47M in Q4 2015.
  • 311 funds tracked by Wall St. Rank held Bausch Health as of Q2 2018.

Based on Clinton Group's 13F filing for Q2 2018, filed 6 Jul 2018.